Enlil Announces Seven Strategic Partnerships

Enlil Announces Seven New Strategic Partnerships

Enlil Announces Seven Strategic Partnerships to Accelerate MedTech Innovation and Customer FDA Clearance Success Campbell, Calif. – July 31, 2025 — Enlil, Inc., a Shifamed Portfolio Company and leader in enabling MedTech product innovation, today announced seven new strategic partnerships formed to date in 2025. These agreements, spanning referral, reseller, deployment, and regulatory consulting collaborations,…

Read More

Enlil’s Purpose Built Development Traceability Platform Gains Momentum Across the Global MedTech Ecosystem

The all-in-one, cloud-native solution integrates AI-powered intelligence to transform how OEMs and contract manufacturers manage development, ensure compliance, and accelerate time-to-market. Campbell, CA – April 28, 2025 – Enlil, Inc., a Shifamed portfolio company accelerating innovation for regulated products with its comprehensive development traceability platform, today announced growing momentum across the global MedTech innovation ecosystem.…

Read More

Poised for Growth, Enlil, a Shifamed Portfolio Company, Appoints Nader Fathi as Chief Executive Officer

Enlil press release announcing the appointment of Nader Fathi as the new CEO

New Leader Set to Propel Global Expansion and Technology Innovation Campbell, CA – March 4, 2025 – Enlil, Inc., a Shifamed portfolio company accelerating innovation for regulated product companies with its comprehensive development traceability platform, today announced the appointment of Nader Fathi as Chief Executive Officer. Nader brings over 30 years of unparalleled experience driving…

Read More